Effects of Different Stressors Are Modulated by Different Neurobiological Systems: The Role of GABA-A Versus CB1 Receptor Gene Variants in Anxiety and Depression
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effects of Different Stressors Are Modulated by Different Neurobiological Systems: The Role of GABA-A Versus CB1 Receptor Gene Variants in Anxiety and Depression
Authors
Keywords
-
Journal
Frontiers in Cellular Neuroscience
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-04-10
DOI
10.3389/fncel.2019.00138
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The state of knowledge about the relationship between 5-HTTLPR, stress, and depression
- (2018) Robert C. Culverhouse et al. JOURNAL OF AFFECTIVE DISORDERS
- Gene-environment interactions between stress and 5-HTTLPR in depression: A meta-analytic update
- (2018) Dries Bleys et al. JOURNAL OF AFFECTIVE DISORDERS
- Significance of risk polymorphisms for depression depends on stress exposure
- (2018) Xenia Gonda et al. Scientific Reports
- Genetic variants in major depressive disorder: From pathophysiology to therapy
- (2018) Xenia Gonda et al. PHARMACOLOGY & THERAPEUTICS
- An endocannabinoid receptor polymorphism modulates affective processing under stress
- (2018) Lisa Wirz et al. Social Cognitive and Affective Neuroscience
- Collaborative meta-analysis finds no evidence of a strong interaction between stress and 5-HTTLPR genotype contributing to the development of depression
- (2017) R C Culverhouse et al. MOLECULAR PSYCHIATRY
- The role of the CNR1 gene in schizophrenia: a systematic review including unpublished data
- (2017) Eduardo S. Gouvêa et al. REVISTA BRASILEIRA DE PSIQUIATRIA
- A new stress sensor and risk factor for suicide: the T allele of the functional genetic variant in the GABRA6 gene
- (2017) Xenia Gonda et al. Scientific Reports
- Distinct types of life events interact with 5-HTTLPR in the development of depressive symptoms in an age-dependent manner
- (2016) X. Gonda et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Variants in theCNR1gene predispose to headache with nausea in the presence of life stress
- (2016) G. Juhasz et al. GENES BRAIN AND BEHAVIOR
- Financial difficulties but not other types of recent negative life events show strong interactions with 5-HTTLPR genotype in the development of depressive symptoms
- (2016) X Gonda et al. Translational Psychiatry
- Association of TMEM132D, COMT, and GABRA6 genotypes with cingulate, frontal cortex and hippocampal emotional processing in panic and major depressive disorder
- (2015) Ayako Inoue et al. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
- Neurobiological Interactions Between Stress and the Endocannabinoid System
- (2015) Maria Morena et al. NEUROPSYCHOPHARMACOLOGY
- Altered γ-aminobutyric acid neurotransmission in major depressive disorder: a critical review of the supporting evidence and the influence of serotonergic antidepressants
- (2015) Alan Pehrson et al. Drug Design Development and Therapy
- Genetic Determinants of Depression
- (2015) Erin C. Dunn et al. HARVARD REVIEW OF PSYCHIATRY
- Variability in the Effect of 5-HTTLPR on Depression in a Large European Population: The Role of Age, Symptom Profile, Type and Intensity of Life Stressors
- (2015) Gabriella Juhasz et al. PLoS One
- The endocannabinoid system: An emotional buffer in the modulation of memory function
- (2014) Maria Morena et al. NEUROBIOLOGY OF LEARNING AND MEMORY
- The Genetics of Major Depression
- (2014) Jonathan Flint et al. NEURON
- Neuronal Nitric Oxide Synthase (NOS1) Polymorphisms Interact with Financial Hardship to Affect Depression Risk
- (2014) Jane E Sarginson et al. NEUROPSYCHOPHARMACOLOGY
- Childhood Poverty and Stress Reactivity Are Associated with Aberrant Functional Connectivity in Default Mode Network
- (2014) Rebecca K Sripada et al. NEUROPSYCHOPHARMACOLOGY
- A critical role for prefrontocortical endocannabinoid signaling in the regulation of stress and emotional behavior
- (2014) Ryan J. McLaughlin et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Cannabinoid Receptor Genotype Moderation of the Effects of Childhood Physical Abuse on Anhedonia and Depression
- (2012) Arpana Agrawal et al. ARCHIVES OF GENERAL PSYCHIATRY
- Prefrontal cortical anandamide signaling coordinates coping responses to stress through a serotonergic pathway
- (2012) Ryan J. McLaughlin et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Interaction between specific forms of childhood maltreatment and the serotonin transporter gene (5-HTT) in recurrent depressive disorder
- (2012) Helen L. Fisher et al. JOURNAL OF AFFECTIVE DISORDERS
- Endocannabinoid system dysfunction in mood and related disorders
- (2011) C. H. Ashton et al. ACTA PSYCHIATRICA SCANDINAVICA
- Alterations in Corticolimbic Dendritic Morphology and Emotional Behavior in Cannabinoid CB1 Receptor-Deficient Mice Parallel the Effects of Chronic Stress
- (2011) M. N. Hill et al. CEREBRAL CORTEX
- The genetic basis of the endocannabinoid system and drug addiction in humans
- (2011) Jose Antonio López-Moreno et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Acute restraint stress enhances hippocampal endocannabinoid function via glucocorticoid receptor activation
- (2011) Meina Wang et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Contributions of endocannabinoid signaling to psychiatric disorders in humans: genetic and biochemical evidence
- (2011) C.J. Hillard et al. NEUROSCIENCE
- Personalized medicine can pave the way for the safe use of CB1 receptor antagonists
- (2011) Judit Lazary et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- CB1 – Cannabinoid Receptor Antagonist Effects on Cortisol in Cannabis-Dependent Men
- (2011) Robert S. Goodwin et al. AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE
- CNR1 gene polymorphisms in addictive disorders: a systematic review and a meta-analysis
- (2010) Amine Benyamina et al. ADDICTION BIOLOGY
- NewMood: A productive European model of collaboration for translational research in depression
- (2010) J.F.W. Deakin et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- The GABAergic deficit hypothesis of major depressive disorder
- (2010) B Luscher et al. MOLECULAR PSYCHIATRY
- Stress Impairs GABAergic Network Function in the Hippocampus by Activating Nongenomic Glucocorticoid Receptors and Affecting the Integrity of the Parvalbumin-Expressing Neuronal Network
- (2010) Wen Hu et al. NEUROPSYCHOPHARMACOLOGY
- Endogenous cannabinoid signaling is essential for stress adaptation
- (2010) M. N. Hill et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Promoter variants of the cannabinoid receptor 1 gene (CNR1) in interaction with5-HTTLPRaffect the anxious phenotype
- (2009) Judit Lazary et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
- Stress and GABAAreceptors
- (2009) Kelly J. Skilbeck et al. JOURNAL OF NEUROCHEMISTRY
- CNR1 Gene is Associated with High Neuroticism and Low Agreeableness and Interacts with Recent Negative Life Events to Predict Current Depressive Symptoms
- (2009) Gabriella Juhasz et al. NEUROPSYCHOPHARMACOLOGY
- Role of cannabis and endocannabinoids in the genesis of schizophrenia
- (2009) Emilio Fernandez-Espejo et al. PSYCHOPHARMACOLOGY
- Hypothalamus–pituitary–adrenal axis evaluation in patients with hypothalamo–pituitary disorders: comparison of different provocative tests
- (2008) R. Giordano et al. CLINICAL ENDOCRINOLOGY
- Cannabinoid receptor 1 (CNR1) gene: Impact on antidepressant treatment response and emotion processing in Major Depression
- (2008) Katharina Domschke et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Regulation of endocannabinoid signaling by stress: Implications for stress-related affective disorders
- (2008) Boris B. Gorzalka et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More